"Stopping Of Covishield Exports Was Huge Problem": Adar Poonawalla
"The stopping of Covishield exports was a huge problem. Part of the reason I went to the UK was to settle lawsuits and also return part of that funding, reinstating commitment to support them later on in the year," says Adar Poonawalla, CEO of Serum Institute of India on how the suspension of vaccine exports impacted them.
